Will Hoth Therapeutics Inc (NASDAQ: HOTH) In 2025 Be Worth Your Money?

In the last trading session, 10.33 million Hoth Therapeutics Inc (NASDAQ:HOTH) shares changed hands as the company’s beta touched 0.68. With the company’s per share price at $1.90 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $13.12M. HOTH’s last price was a discount, traded about -100.0% off its 52-week high of $3.80. The share price had its 52-week low at $0.58, which suggests the last value was 69.47% up since then. When we look at Hoth Therapeutics Inc’s average trading volume, we note the 10-day average is 50.25 million shares, with the 3-month average coming to 8.76 million.

Analysts gave the Hoth Therapeutics Inc (HOTH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HOTH as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.

Hoth Therapeutics Inc (NASDAQ:HOTH) trade information

The company’s shares are showing year-to-date upside of 153.98%, with the 5-day performance at 146.72% in the green. However, in the 30-day time frame, Hoth Therapeutics Inc (NASDAQ:HOTH) is 121.19% up. Looking at the short shares, we see there were 0.29 million shares sold at short interest cover period of 0.26 days.

Hoth Therapeutics Inc (HOTH) estimates and forecasts

Data shows that the Hoth Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 108.79% over the past 6 months, a 48.70% in annual growth rate that is considerably higher than the industry average of 16.40%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.18%. The 2025 estimates are for Hoth Therapeutics Inc earnings to increase by 44.78%.

HOTH Dividends

Hoth Therapeutics Inc is expected to release its next quarterly earnings report in February.

Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.92% of Hoth Therapeutics Inc shares while 5.31% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.36%.